NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea
· Delayed Price · Currency is KRW 1,938.00
+95.00 (5.15%)
At close: Aug 8, 2025, 3:30 PM KST
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 48.62 billion as of August 14, 2025. Its market cap has increased by 31.44% in one year.
Market Cap
48.62B
Enterprise Value
52.87B
Revenue
6.85B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,938.00
Market Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 48.62B, a decrease of -84.48%. That is a compound annual growth rate of -32.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 48.00B | 48.09% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.23% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | 379.90B | 21.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 470.21T |
| SK hynix | 191.92T |
| LG Energy Solution | 91.14T |
| Samsung Biologics | 74.02T |
| Hyundai Motor Company | 47.20T |
| Hanwha Aerospace | 45.17T |
| Doosan Enerbility | 42.59T |
| HD Hyundai Heavy Industries | 41.46T |